SCHEMBL4847293

SCHEMBL4847293

N#C/C=C/c1ccc(F)c(Cl)c1.O=Cc1ccc(F)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A3 P47895 3/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ENPP2 Q13822 1/20 0.36
FDPS P14324 1/20 0.36
VCAM1 P19320 1/20 0.35
ALDH3A1 P30838 2/20 0.35
TRPA1 O75762 1/20 0.34
TTR P02766 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EGFR P00533 1/20 0.33
IDO1 P14902 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29472390 0.83 ALDH1A1 (0.64) ALDH1A1KMT2AALDH1A3HSD17B10KDM4E
SCHEMBL42757 0.83 ALDH1A1 (0.64) ALDH1A1KMT2AALDH1A3HSD17B10KDM4E
Hydrochloric Acid SCHEMBL30783012 0.81 ALDH1A1 (0.61) ALDH1A1POLBPKMMAPK1KMT2A
SCHEMBL6349916 0.78 KDM4E (0.42) ALDH1A1KDM4EENPP2FDPS
SCHEMBL2360504 0.78 TRPA1 (0.38) ALDH1A1POLBPKMMAPK1KMT2A
SCHEMBL2360503 0.78 TRPA1 (0.38) ALDH1A1POLBPKMMAPK1KMT2A
SCHEMBL6349913 0.78 KDM4E (0.42) ALDH1A1KDM4EENPP2FDPS
SCHEMBL2779298 0.76 ALDH1A1 (0.48) ALDH1A1KMT2AKDM4EENPP2FDPS
SCHEMBL10734385 0.76 ALDH1A1 (0.48) ALDH1A1KMT2AKDM4EENPP2FDPS
SCHEMBL15282103 0.76 NFE2L2 (0.52) KDM4EENPP2FDPSTRPA1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462620-B2 Pyrimidinone derivatives and their use in the treatment of atherosclerosis SMITHKLINE BEECHAM, PLC (GB) 2008-12-09 US disclosed